APA (7th ed.) Citation

Y, H., J, Z., Z, Y., H, Z., Y, W., A, L., . . . C, O. (2017). Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy. Journal of medicinal chemistry, 60(6), 2215. https://doi.org/10.1021/acs.jmedchem.6b01576

Chicago Style (17th ed.) Citation

Y, Huang, et al. "Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy." Journal of Medicinal Chemistry 60, no. 6 (2017): 2215. https://doi.org/10.1021/acs.jmedchem.6b01576.

MLA (9th ed.) Citation

Y, Huang, et al. "Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy." Journal of Medicinal Chemistry, vol. 60, no. 6, 2017, p. 2215, https://doi.org/10.1021/acs.jmedchem.6b01576.